The Market Analyzer
  • Business
  • Investing
  • Economy
  • Stock
Trending Now
Larry Williams on the Fed, Interest Rates &...
Top Sectors to Watch + The 18 SMA...
Two Lithium Zones Confirmed in Latest Drill- Hole...
Silver Reserves: Top 5 Countries
QEM Appoints New CEO as It Secures $2.05M...
Quimbaya Gold Announces Strategic Private Placement of up...
Fintech Firm Velocity Raises US$10 Million for Enterprise...
Platinum Price Breaks Out as Chinese Demand and...
Freegold Provides Update on 2025 Drill Program
Coelacanth Announces Q1 2025 Financial and Operating Results

The Market Analyzer

  • Business
  • Investing
  • Economy
  • Stock
Investing

Larisa Sprott: Gold, Silver Early in Cycle, Smart Money Buying Now

by admin May 28, 2025
May 28, 2025
Larisa Sprott: Gold, Silver Early in Cycle, Smart Money Buying Now

Larisa Sprott of Sprott Money and Argo shares her thoughts on the gold and silver markets, saying she sees the ‘smart money’ continuing to gravitate toward these metals.

In her view, price dips present a chance to get in at lower levels.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
ARR advances permitting at Cowboy State Mine
next post
Zijin to Take on Precious Metals Streaming as Gold Price Soars

Related Posts

Radiopharm Theranostics to Participate in the D. Boral...

May 7, 2025

Top 5 Canadian Mining Stocks This Week: Tag...

April 26, 2025

Quimbaya Gold and Denarius Metals Partner to Formalize...

May 7, 2025

AngloGold Sells Two African Assets to Resolute Mining

May 6, 2025

Triumph Gold: Multi-million-ounce, District-scale Gold Assets in the...

May 7, 2025

EL2780 Award – New Targets from Airborne MT

May 15, 2025

Update – Blackstone Merger to Acquire Copper Gold...

May 7, 2025

Coinbase Backs QCAD Stablecoin to Power Canadian Crypto...

May 17, 2025

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving...

May 5, 2025

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical...

May 13, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Larry Williams on the Fed, Interest Rates & Markets! What’s Next?
    • Top Sectors to Watch + The 18 SMA Setup Every Trader Should Know
    • Two Lithium Zones Confirmed in Latest Drill- Hole at Red Mountain Project, USA
    • Silver Reserves: Top 5 Countries
    • QEM Appoints New CEO as It Secures $2.05M in Strongly Supported Placement

    Popular Posts

    • 1

      Stock Market News UK Update: FTSE 100 & 250 Rise

      April 16, 2025
    • 2

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

      April 21, 2025
    • 3

      Stock Market News UK Update: FTSE 100 & 250 Rise

      April 17, 2025
    • 4

      Stock Market News UK Update: FTSE 100 & 250 Rise

      April 17, 2025
    • 5

      Stock Market News UK Update: FTSE 100 & 250 Rise

      April 20, 2025

    Categories

    • Business (72)
    • Economy (20)
    • Investing (275)
    • Stock (126)
    Footer Logo
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: themarketanalyzer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 themarketanalyzer.com | All Rights Reserved